Zhejiang Anglikang Pharmaceutical Co Ltd Class A Cash Flow Conversion Efficiency
Zhejiang Anglikang Pharmaceutical Co Ltd Class A cash flow conversion efficiency. Based on the latest financial reports, Zhejiang Anglikang Pharmaceutical Co Ltd Class A (002940) has a cash flow conversion efficiency ratio of 0.062x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥112.57 Million ≈ $16.47 Million USD) by net assets (CN¥1.83 Billion ≈ $267.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)
Cash flow conversion efficiency of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. This chart illustrates how Zhejiang Anglikang Pharmaceutical Co Ltd Class A's cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Zhejiang Anglikang Pharmaceutical Co Ltd for real-time trading data and today's change.
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Cash Flow Conversion Ratio Explained
Zhejiang Anglikang Pharmaceutical Co Ltd Class A cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Zhejiang Anglikang Pharmaceutical Co Ltd Class A Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Anglikang Pharmaceutical Co Ltd Class A ranked by their cash flow conversion efficiency. Also see Zhejiang Anglikang Pharmaceutical Co Ltd stock valuation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Xianheng International Science & Technology Co Ltd
SHG:605056
|
N/A |
|
Hite Jinro
KO:000080
|
0.090x |
|
Shandong Link Science and Technology Co Ltd
SHE:001207
|
0.031x |
|
Time Publishing and Media Co Ltd Class A
SHG:600551
|
-0.006x |
|
Tianma Bearing Group Co Ltd
SHE:002122
|
0.003x |
|
Shenzhen Terca Technology Co Ltd
SHE:002213
|
-0.254x |
|
Zenner Metering Technology (Shanghai) Ltd. A
SHE:301303
|
N/A |
|
Sunway Co Ltd
SHG:603333
|
0.095x |
Annual Cash Flow Conversion Efficiency for Zhejiang Anglikang Pharmaceutical Co Ltd Class A (2014–2025)
The table below shows the annual cash flow conversion efficiency of Zhejiang Anglikang Pharmaceutical Co Ltd Class A from 2014 to 2025. Review Zhejiang Anglikang Pharmaceutical Co Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥1.87 Billion ≈ $273.23 Million |
CN¥244.13 Million ≈ $35.72 Million |
0.131x | -7.28% |
| 2024-12-31 | CN¥1.80 Billion ≈ $263.17 Million |
CN¥253.60 Million ≈ $37.11 Million |
0.141x | -6.69% |
| 2023-12-31 | CN¥1.83 Billion ≈ $268.12 Million |
CN¥276.91 Million ≈ $40.52 Million |
0.151x | +34.66% |
| 2022-12-31 | CN¥1.65 Billion ≈ $240.88 Million |
CN¥184.75 Million ≈ $27.03 Million |
0.112x | -16.25% |
| 2021-12-31 | CN¥1.47 Billion ≈ $215.83 Million |
CN¥197.65 Million ≈ $28.92 Million |
0.134x | -7.03% |
| 2020-12-31 | CN¥1.38 Billion ≈ $201.64 Million |
CN¥198.61 Million ≈ $29.06 Million |
0.144x | -31.38% |
| 2019-12-31 | CN¥1.02 Billion ≈ $148.74 Million |
CN¥213.49 Million ≈ $31.24 Million |
0.210x | +52.63% |
| 2018-12-31 | CN¥970.93 Million ≈ $142.08 Million |
CN¥133.61 Million ≈ $19.55 Million |
0.138x | -71.99% |
| 2017-12-31 | CN¥394.37 Million ≈ $57.71 Million |
CN¥193.77 Million ≈ $28.36 Million |
0.491x | +13.50% |
| 2016-12-31 | CN¥327.43 Million ≈ $47.91 Million |
CN¥141.74 Million ≈ $20.74 Million |
0.433x | -17.47% |
| 2015-12-31 | CN¥264.20 Million ≈ $38.66 Million |
CN¥138.59 Million ≈ $20.28 Million |
0.525x | +125.68% |
| 2014-12-31 | CN¥217.08 Million ≈ $31.77 Million |
CN¥50.46 Million ≈ $7.38 Million |
0.232x | -- |
About Zhejiang Anglikang Pharmaceutical Co Ltd Class A
Zhejiang AngLiKang Pharmaceutical CO.,LTD. engages in the research, development, production, and sale of pharmaceuticals in China and internationally. The company offers chemical raw materials for pharmaceuticals comprising oral cephalosporin antibiotic raw materials, including cephalexin, cefadroxil, cefaclor, and cefadroxil; alpha-keto acid raw materials; inhaled anesthetic raw materials, such … Read more